| Symbol | ELVAF |
|---|---|
| Name | EVOLVA HOLDING AG |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | - |
| Address | CH-4153 Switzerland 23 Duggingerstrasse |
| Telephone | +41 61 485 2000 |
| Fax | — |
| — | |
| Website | http://www.evolva.com/ |
| Incorporation | — |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: SIX Swiss Exchange |
| CIK | 0001571860 |
| Description | Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature made ingredient via fermentation that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. Additional info from OTC: |
No news found.